Immunotherapy with allogeneic neuraminidase-treated blasts for maintenance in acute myelogenous leukemia (AML). Significant prolongation of remission duration in patients receiving at least 3 cycles of therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples